Hemolytic Uremic Syndrome and SARS-CoV-2 Infection: A Rare Association
Medicina Interna · 13.02.2023
DOI: 10.24950/rspmi.1616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Interna, erschienen am 13.02.2023. Verfasst von C. Honrado Martins und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Thrombotic microangiopathies (TMA) are rare diseases, with high morbimortality. Among them, atypical hemolytic uremic syndrome (HUS), associated with deregulation of alternative complement pathway (genetic/acquired), represents a diagnostic challenge. Characterized by thrombotic microangiopathy, acute renal failure is one of its main features. Etiological/ precipitant detection (TMA triggers) is essential, even though about 30% of cases remain idiopathic. There is not a direct diagnostic test, which makes this an exclusion final diagnosis (after primary and secondary causes are ruled-out). Further testing for genetic variations is important for prognostic purposes. We describe the case of a 40 years old woman, whose final diagnostic was an atypical HUS associated with SARS- -CoV-2 infection. This case stands out by its rarity. We underline the importance of prompt initial diagnosis and timely target treatment beginning: Eculizumab, the only one available in Portugal at the moment. Plasmapheresis and/or renal replacement therapy must be considered case by case.
Schlagwörter
Zitieren
APA
Martins, C. H., Costa, D., José, Pereira, Paulo, Matos, Rita, A., Gomes, Vânia, & Castro-Gomes, G. (2023). Hemolytic Uremic Syndrome and SARS-CoV-2 Infection: A Rare Association. Medicina Interna. https://doi.org/10.24950/rspmi.1616
Vancouver
Martins CH, Costa D, José, Pereira, Paulo, Matos, et al. Hemolytic Uremic Syndrome and SARS-CoV-2 Infection: A Rare Association. Medicina Interna. 2023. doi:10.24950/rspmi.1616
BibTeX
@article{Martins2023,
author = {Martins, C. Honrado and Costa, Damasceno and José and Pereira and Paulo and Matos and Rita, Ana and Gomes and Vânia and Castro-Gomes, Guilherme},
title = {Hemolytic Uremic Syndrome and SARS-CoV-2 Infection: A Rare Association},
journal = {Medicina Interna},
year = {2023},
doi = {10.24950/rspmi.1616}
}
EUVIMED